296 related articles for article (PubMed ID: 26970205)
21. Formation of oligonucleotide-gated silica shell-coated Fe₃O₄-Au core-shell nanotrisoctahedra for magnetically targeted and near-infrared light-responsive theranostic platform.
Li WP; Liao PY; Su CH; Yeh CS
J Am Chem Soc; 2014 Jul; 136(28):10062-75. PubMed ID: 24953310
[TBL] [Abstract][Full Text] [Related]
22. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
23. Core/shell nanoparticles for pH-sensitive delivery of doxorubicin.
Oh KS; Um YS; Lee JH; Cho SH; Lee KE; Han SS; Kim D; Yuk SH
J Nanosci Nanotechnol; 2010 Oct; 10(10):6967-71. PubMed ID: 21137835
[TBL] [Abstract][Full Text] [Related]
24. Designing Core-Shell Gold and Selenium Nanocomposites for Cancer Radiochemotherapy.
Chang Y; He L; Li Z; Zeng L; Song Z; Li P; Chan L; You Y; Yu XF; Chu PK; Chen T
ACS Nano; 2017 May; 11(5):4848-4858. PubMed ID: 28460158
[TBL] [Abstract][Full Text] [Related]
25. Treatment of metastatic breast cancer by combination of chemotherapy and photothermal ablation using doxorubicin-loaded DNA wrapped gold nanorods.
Wang D; Xu Z; Yu H; Chen X; Feng B; Cui Z; Lin B; Yin Q; Zhang Z; Chen C; Wang J; Zhang W; Li Y
Biomaterials; 2014 Sep; 35(29):8374-84. PubMed ID: 24996756
[TBL] [Abstract][Full Text] [Related]
26. In vivo distribution and antitumor activity of doxorubicin-loaded N-isopropylacrylamide-co-methacrylic acid coated mesoporous silica nanoparticles and safety evaluation.
Chen Y; Yang W; Chang B; Hu H; Fang X; Sha X
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):406-12. PubMed ID: 23816639
[TBL] [Abstract][Full Text] [Related]
27. Dual targeting luminescent gold nanoclusters for tumor imaging and deep tissue therapy.
Chen D; Li B; Cai S; Wang P; Peng S; Sheng Y; He Y; Gu Y; Chen H
Biomaterials; 2016 Sep; 100():1-16. PubMed ID: 27236844
[TBL] [Abstract][Full Text] [Related]
28. Anti-cancer drug loaded iron-gold core-shell nanoparticles (Fe@Au) for magnetic drug targeting.
Kayal S; Ramanujan RV
J Nanosci Nanotechnol; 2010 Sep; 10(9):5527-39. PubMed ID: 21133071
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
30. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
31. Brain-targeted delivery of doxorubicin using glutathione-coated nanoparticles for brain cancers.
Geldenhuys W; Wehrung D; Groshev A; Hirani A; Sutariya V
Pharm Dev Technol; 2015 Jun; 20(4):497-506. PubMed ID: 24597667
[TBL] [Abstract][Full Text] [Related]
32. Magnetic/NIR-responsive drug carrier, multicolor cell imaging, and enhanced photothermal therapy of gold capped magnetite-fluorescent carbon hybrid nanoparticles.
Wang H; Cao G; Gai Z; Hong K; Banerjee P; Zhou S
Nanoscale; 2015 May; 7(17):7885-95. PubMed ID: 25854197
[TBL] [Abstract][Full Text] [Related]
33. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors.
Byeon HJ; Thao le Q; Lee S; Min SY; Lee ES; Shin BS; Choi HG; Youn YS
J Control Release; 2016 Mar; 225():301-13. PubMed ID: 26826308
[TBL] [Abstract][Full Text] [Related]
34. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
[TBL] [Abstract][Full Text] [Related]
35. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
Zhang C; Wu Y; Dong Y; Xu H; Zhao L
Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo evaluation of anti-nucleolin-targeted magnetic PLGA nanoparticles loaded with doxorubicin as a theranostic agent for enhanced targeted cancer imaging and therapy.
Mosafer J; Abnous K; Tafaghodi M; Mokhtarzadeh A; Ramezani M
Eur J Pharm Biopharm; 2017 Apr; 113():60-74. PubMed ID: 28012991
[TBL] [Abstract][Full Text] [Related]
37. Structure-directing star-shaped block copolymers: supramolecular vesicles for the delivery of anticancer drugs.
Yang C; Liu SQ; Venkataraman S; Gao SJ; Ke X; Chia XT; Hedrick JL; Yang YY
J Control Release; 2015 Jun; 208():93-105. PubMed ID: 25813888
[TBL] [Abstract][Full Text] [Related]
38. LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo.
He C; Zhang Z; Ding Y; Xue K; Wang X; Yang R; An Y; Liu D; Hu C; Tang Q
J Nanobiotechnology; 2021 Jan; 19(1):29. PubMed ID: 33482822
[TBL] [Abstract][Full Text] [Related]
39. Doxorubicin loaded magnetic gold nanoparticles for in vivo targeted drug delivery.
Elbialy NS; Fathy MM; Khalil WM
Int J Pharm; 2015 Jul; 490(1-2):190-9. PubMed ID: 25997662
[TBL] [Abstract][Full Text] [Related]
40. Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery.
Shao D; Wang Z; Dong WF; Zhang X; Zheng X; Xiao XA; Wang YS; Zhao X; Zhang M; Li J; Huo QS; Chen L
Chem Biol Drug Des; 2015 Dec; 86(6):1548-53. PubMed ID: 26216620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
